Mizuho on Abbott Labs (ABT): 'Nutrition Spin Well-Telegraphed as Attention Shifts to Libre & C+'

October 22, 2026 7:54 AM EDT Send to a Friend
Mizuho analyst Anthony Petrone reiterated a Neutral rating and $115.00 price target on Abbott Labs (NYSE: ABT).The analyst comments "Key ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login